Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_assertion type Assertion NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_head.
- NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_assertion description "[Though RT-PCR is highly sensitive in detecting CBFB/MYH11 fusion transcripts during remission, monitoring of minimal residual disease in patients with inv(16) remains to be established.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_provenance.
- NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_assertion evidence source_evidence_literature NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_provenance.
- NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_assertion SIO_000772 7577615 NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_provenance.
- NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_assertion wasDerivedFrom befree-20140225 NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_provenance.
- NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_assertion wasGeneratedBy ECO_0000203 NP585303.RAuHSEq3L7sm6HVfO5UuRv8U1ne55knQchds-qc_6-RWs130_provenance.